Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Hyun Bang

Vascular & Interventional Radiology Brandywine, MD Medical Doctor

NPI 1336452036 CMS profile 105782

7704 Matapeake Business Dr Ste 130, Brandywine, MD 20613

Open in the dashboard

General payments

$31,346

423 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Hyun Bang of Brandywine, MD is reported in the CMS Open Payments database as having received $31,346 across 423 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 88th percentile of Vascular & Interventional Radiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $3,358 68
2024 General $3,489 86
2023 General $3,203 84
2022 General $2,899 69
2021 General $2,178 26
2020 General $3,532 34
2019 General $12,687 56

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Hyun Bang
  • Vascular & Interventional Radiology median
  • Middle half of Vascular & Interventional Radiology
  • National median

In program year 2025, general payments to Hyun Bang were reported at $3,358. Among 3,393 Vascular & Interventional Radiology profiles paid that year, the median was $534 and the middle half received between $166 and $2,075.

Show as a table
Year Hyun Bang Vascular & Interventional Radiology median Middle half National median
2019 $12,687 $422 $125–$1,555 $163
2020 $3,532 $200 $68–$652 $114
2021 $2,178 $280 $99–$866 $132
2022 $2,899 $433 $137–$1,497 $149
2023 $3,203 $506 $152–$2,019 $160
2024 $3,489 $556 $175–$1,930 $164
2025 $3,358 $534 $166–$2,075 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. AngioDynamics, Inc. $9,245 157 payments
  2. Biocompatibles, Inc. $8,059 3 payments
  3. Abbott Laboratories $6,483 74 payments
  4. Philips Electronics North America Corporation $2,225 70 payments
  5. Boston Scientific Corporation $1,973 43 payments
  6. Cardiovascular Systems Inc. $1,954 38 payments
  7. Cordis US Corp. $338 5 payments
  8. Bard Peripheral Vascular, Inc. $225 8 payments
  9. Medtronic, Inc. $206 2 payments
  10. Terumo Medical Corporation $129 5 payments
  11. Other $511 18 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $19,904 419 payments
  2. Consulting Fee $6,900 1 payment
  3. Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program $2,200 1 payment
  4. Education $1,250 1 payment
  5. Travel and Lodging $1,093 1 payment
Products named General payments · program years 2019–2025
  1. THERASPHERE - BIO $8,059 3 payments
  2. AURYON LASER SYSTEM 100-120 VAC Pad $4,806 110 payments
  3. Xience V coronary stent system $2,200 1 payment
  4. Auryon $1,250 1 payment
  5. Auryon Laser System 100-120 Vac Et $1,075 1 payment
  6. Smart Port CT $1,058 33 payments
  7. Diamondback Peripheral Vascular $1,006 12 payments
  8. Peripheral Orbital Atherectomy System $987 21 payments
  9. Diamondback Peripheral Atherectomy Device $967 17 payments
  10. (6577) Visions 014 $799 24 payments
  11. Other $8,426 204 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 1 drug

Part D claims

125

Median for Interventional Radiology: 38

Drug cost

$1,455

Median for Interventional Radiology: $333

Branded share of claims

100%

Median for Interventional Radiology: 53%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Clopidogrel Clopidogrel Bisulfate Brand 125 $1,455

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 554 Part D prescribers listed as Interventional Radiology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 37 billing codes

Paid by Medicare

$1,221,120

Medicare's payments for the services billed

Medicare patients

1,191

Average age 75

Services billed

5,225

719 women, 472 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Diabetes 63%
Arthritis 55%
Chronic kidney disease 40%
Ischemic heart disease 30%
Cancer 24%
COPD 19%
Heart failure 18%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

423 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Vascular & Interventional Radiology in Maryland

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record